Tekla Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in Intercept Pharmaceuticals, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 52,067 shares of ICPT stock, worth $0. This represents 0.02% of its overall portfolio holdings.
Number of Shares
52,067
Previous 52,067
-0.0%
Holding current value
$0
Previous $699,000
17.74%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding ICPT
# of Institutions
6Shares Held
1.04MCall Options Held
30KPut Options Held
5.9KAbout INTERCEPT PHARMACEUTICALS, INC.
- Ticker ICPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,127,400
- Description
- Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...